Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack

• Status: Withdrawn
• Trial end date: 2007-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Pilot study of continuing aspirin versus switching to clopidogrel after stroke or transient ischemic attack.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of California, San Diego
• Treatments: Aspirin; Clopidogrel; Ticlopidine

Criteria

Inclusion Criteria:

• Age 18 and older.

• Stroke or transient ischemic attack (TIA) while taking aspirin within one week of consent.

• Women of child-bearing potential will be included only if there is a negative pregnancy test and they agree to birth control during the treatment period.

Exclusion Criteria:

• Any medical indication for a specific antiplatelet agent (aspirin, clopidogrel, ticlopidine, aggrenox), or an indication for a combination of antiplatelet agents.

• Any medical indication for anticoagulation, except subcutaneous heparin for deep vein thrombosis prophylaxis.

• Allergy to aspirin or clopidogrel.